3175 results for «439»
3175 results
Complex mitral interventions
19 Nov 2023 – From PCR London Valves 2023
What are the one-year outcomes of transfemoral TMVR? How does TMVI compare with SMVR in elderly patients at intermediate risk? What is the value of mitral ViV and mitral valve-in-ring in high-surgical-risk patients? Find the answers here!
TAVI - computer simulation and pre-procedural modelling
19 Nov 2023 – From PCR London Valves 2023
TAVI for aortic regurgitation
19 Nov 2023 – From PCR London Valves 2023
In the face of aortic regurgitation, learn about various TAVI rescue techniques in this session, including valve implantation in the descending aorta, TAVI treatment of aortic regurgitation with cardiogenic shock, and TAVI management of aortic regurgitation in a patient with a left ventricular assist device.
TAVI - Alternative access - Part 1
19 Nov 2023 – From PCR London Valves 2023
Learn more about the evolving landscape of TAVI techniques and access options with this session: experience the first-hand application of JenaValve Trilogy via transaxillary access in treating aortic regurgitation, delve into the challenges and solutions of transcaval TAVI in a patient with right iliac vein occlusion,...
TAVI: haemodynamic considerations
19 Nov 2023 – From PCR London Valves 2023
Consult this session to gain a comprehensive understanding of the hemodynamic considerations in TAVI: delve into the comparative analysis of invasive and echocardiographic assessments to discern transvalvular pressure gradients post-TAVI, witness the validation of non-invasive volume-pressure loop analysis as an effective tool for patients with aortic...
Mitral TEER - Part 1
19 Nov 2023 – From PCR London Valves 2023
Consult this session to gain insights into the complexities of Mitral TEER: witness an innovative solution for recurrent mitral regurgitation post-M-TEER showcasing the efficacy of three MitraClips, navigate the challenging terrain of mitral flail repair in a patient with a left main chronic total occlusion, explore...
Complications of mitral valve interventions
19 Nov 2023 – From PCR London Valves 2023
Learn more about the complexities of mitral valve interventions with this selection of cases: witness the challenges posed by clip embolisation during Mitral TEER, delve into the scenario of SAM following TMVI leading to left ventricular outflow tract obstruction, explore the closure of an iatrogenic ASD...
TAVI in bicuspid anatomy - Part 1
19 Nov 2023 – From PCR London Valves 2023
Delve into the complexities of TAVI within bicuspid anatomy through this selection of cases: encounter a challenging scenario with a bicuspid aortic valve, where the ejection fraction is -14%, coupled with left ventricle thrombus and an aortic valve calcium score reaching 11,000, learn more about the...
Late-breaking trials on latest-generation aortic valves and dedicated transcatheter devices
20 Nov 2023 – From PCR London Valves 2023
Find out the outcomes of the main studies on the latest-generation valves and devices presented at PCR LV 2023 to better determine their benefits, performance and interest in the treatment of specific aortic pathologies: REACCESS-2 Study, ACURATE Neo2 PMCF post-market registry, OCEAN-TAVI registry, ShortCut Pivotal Study, and...
Tricuspid TEER - Part 1
19 Nov 2023 – From PCR London Valves 2023
Gain insights into Tricuspid Transcatheter Edge-to-Edge Repair (TEER) with this session: explore the congestion patterns observed in severe tricuspid regurgitation and gain a deeper understanding of transcatheter treatment modalities, delve into the baseline characteristics of the Tri.Fr randomized trial on treating tricuspid regurgitation, witness the application...
TAVI in cardiogenic shock
19 Nov 2023 – From PCR London Valves 2023
Because TAVI implantation, a routine procedure, is not always a breeze, look at a number of challenging cases, including a case of aortic stenosis complicated by cardiogenic shock, an emergency valve-in-valve TAVI, or a TAVI for left ventricular assist device.
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial
07 Nov 2022
Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.
This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...
Author
Three-year results of HOST-POLYTECH-ACS RCT comparing durable- vs. degradable-polymer DES
30 Aug 2023
Alex Sticchi provides his take on the 3-year results of HOST-POLYTECH-ACS RCT which were presented by Hyo-Soo Kim during the ESC 2023 congress in Amsterdam.
Author
Evidence base: A description of the key, so far published, studies in the space of drug coated balloons
23 Jan 2025
Authored by Hector Garcia-Garcia and Jorge Sanz-Sanchez, this article examines pivotal randomized clinical trials on drug-coated balloons in coronary artery disease. It highlights their role in managing in-stent restenosis, de novo small vessel lesions, and large vessel lesions while exploring future directions through ongoing trials.
Author
Author
NEO-MINDSET: Early withdrawal of aspirin after percutaneous coronary intervention for acute coronary syndrome
02 Sep 2025
Daniele Giacoppo reports and provides his perspective on the main results of the ambitious NEOMINDSET trial, presented by Pedro Lemos from the Hospital Israelita Albert Einstein, São Paulo, Brazil, during a Late Breaking Trials session at the ESC Congress 2025 in Madrid, and simultaneously published in the New...
Author
